NYSEARCA:MTUL ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN (MTUL) Price, Holdings, & News $30.10 0.00 (0.00%) (As of 10/29/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChart About ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN (NYSEARCA:MTUL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MTUL alerts:Sign Up Key Stats Today's Range$30.10▼$30.1250-Day Range$23.49▼$30.8152-Week Range$14.33▼$31.78Volume184 shsAverage Volume593 shsMarket Capitalization$30.10 millionAssets Under Management$9.02 millionDividend Yield0.00%Net Expense Ratio0.95%Aggregate RatingN/A ETF OverviewThe ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN (MTUL) is an exchange-traded fund that is based on the MSCI USA Momentum index. The fund provides 2x leveraged exposure to an index of US large- and mid-cap securities selected and weighted based on momentum. MTUL was launched on Feb 5, 2021 and is issued by ETRACS.Read More… The most serious warning of my career (Ad)With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the financial world in two the moment the polls close. I predict they could see investment losses of 50% (or more) in the weeks following the presidential election. Click here now to grab your seat now. ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN ExpensesTypeMTULStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.95%0.47%0.55%0.51%0.52%Other Expenses0.00%0.39%0.49%0.58%0.53%Total Expense0.95%0.62%0.71%0.73%0.71%Fee Waiver0.00%-0.42%-0.52%-0.68%-0.57%Net Expense0.95%0.53%0.61%0.58%0.59% Receive MTUL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN and its competitors with MarketBeat's FREE daily newsletter. Email Address MTUL ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com MTUL ETF - Frequently Asked Questions How have MTUL shares performed this year? ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN's stock was trading at $18.64 at the beginning of 2024. Since then, MTUL shares have increased by 61.5% and is now trading at $30.1002. View the best growth stocks for 2024 here. How do I buy shares of ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN? Shares of MTUL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Fund Details IssuerUBS Fund NameETRACS 2x Leveraged MSCI US Momentum Factor TR ETN Tax ClassificationExchange-Traded Note Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:MTUL Inception Date2/5/2021 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMSCI USA Momentum GR USD CategoryBroad Equity FocusStrategy Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$9.02 million Average Daily Volume$0.00 Discount/Premium0.02% Leveraged2.00 Administrator, Advisor and Custodian AdministratorN/A AdvisorUBS AG CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerIMC Options OptionableN/A Short Interest400 shs Miscellaneous Outstanding Shares1,000,000Beta2.29 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report This page (NYSEARCA:MTUL) was last updated on 10/30/2024 by MarketBeat.com Staff From Our Partners625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredThe most serious warning of my careerWith the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredThis biotech's ONE drug could change medicine as we know itThis Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses...Smallcaps Daily | Sponsored2 Pro Traders… 4 Livestreams… 4 Live TradesThe Zero Day Loophole: The Secret of HUGE Overnight Profits from Government ReportsMonument Traders Alliance | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredIs your portfolio prepared for AI 2.0?AI has exploded ever since ChatGPT set the world on fire near the end of 2022. Numerous companies with conn...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN Please log in to your account or sign up in order to add this asset to your watchlist. Share ETRACS 2x Leveraged MSCI US Momentum Factor TR ETN With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.